| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69292-204-10 | 69292-204 | HUMAN PRESCRIPTION DRUG | Terazosin Hydrochloride | Terazosin Hydrochloride | CAPSULE | ORAL | 20260520 | N/A | ANDA | ANDA074823 | Amici Pharma, Inc. | TERAZOSIN HYDROCHLORIDE | 10 mg/1 | 1000 CAPSULE in 1 BOTTLE (69292-204-10) |
| 71610-595-60 | 71610-595 | HUMAN PRESCRIPTION DRUG | Terazosin Hydrochloride | Terazosin Hydrochloride | CAPSULE | ORAL | 20210826 | N/A | ANDA | ANDA074823 | Aphena Pharma Solutions - Tennessee, LLC | TERAZOSIN HYDROCHLORIDE | 5 mg/1 | 90 CAPSULE in 1 BOTTLE (71610-595-60) |
| 71610-595-80 | 71610-595 | HUMAN PRESCRIPTION DRUG | Terazosin Hydrochloride | Terazosin Hydrochloride | CAPSULE | ORAL | 20210826 | N/A | ANDA | ANDA074823 | Aphena Pharma Solutions - Tennessee, LLC | TERAZOSIN HYDROCHLORIDE | 5 mg/1 | 180 CAPSULE in 1 BOTTLE (71610-595-80) |